The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's ...

Federal officials promised on Tuesday to crack down on a potent semisynthetic opioid found in gas store gummies, drinks and ...

A federal judge on July 28 ordered the opioid case against Publix closed due to both sides agreeing to a settlement.

The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications ...

In a significant move aimed at combating the ongoing opioid epidemic, the U.S. Food and Drug Administration (FDA) has announced major ...

Republican lawmakers on the committee, who nearly unanimously voted against the measure, voiced concern about the centers’ ...

The FDA is requiring opioid pain medication manufacturers to update safety labeling with a stronger emphasis on risks from long-term use, including addiction and overdose death.

The new rule comes after a public advisory committee meeting in May that reviewed data showing risks for patients who use opioids over long periods. Those risks include misuse, addiction and overdoses ...

The City Council's Public Safety Committee heard about opioid trends and potential solutions to the drug crisis during a ...

The FDA hopes education and legal action against 7-OH products will help prevent a second opioid crisis in the US.

Routinely offering and initiating medication-based treatment for those with opioid use disorder has the potential to save ...